PureTech Health celebrates drug designation for LYT-200 from

PureTech Health PLC on Wednesday touted the efficacy of its acute myeloid leukaemia therapy, after securing a regulatory designation from the US Food & Drug Administration.

According to the Boston,...

Related Keywords

Massachusetts , United States , Boston , Holly Beveridge , Amir Fathi , Puretech Health , Alliance News Ltd , Leukaemia Programme At Massachusetts , Us Food Drug Administration , Alliance News , Tech Health , Orphan Drug , Leukaemia Programme , Massachusetts General Hospital , All Rights ,